Benvenuti sul sito web di Farmacovigilanza

Feed rss AIFA: Notizia

29/04/2026

AIFA pubblica il Terzo Position Paper sui farmaci biosimilari: focus su intercambiabilità, "switch informato" e sostenibilità del SSN

Ultime notizie

26/03/2026

C’è un legame tra fatigue ed eventi avversi correlati alle terapie oncologiche?

Biblioteca Virtuale per la Salute – Piemonte

24/04/2026

Newsletter trimestrale Medicina di Genere – aprile 2026

Agendas and minutes

28/04/2026

Agenda - European Platform for Regulatory Science Research meeting

Consumer Updates RSS Feed

20/04/2026

Animal Welfare, Testing and Research of FDA-Regulated Products

Regulatory and procedural guidelines (human and veterinary)

30/04/2026

List of centrally authorised products with safety-related changes to the product information

Scientific guidelines (human and veterinary)

29/04/2026

Annexes to ICH Q3C guideline on impurities: guideline for residual solvents (EMA/CHMP/ICH/82260/2006) and VICH GL18 Impurities: residual solvents in new veterinary medicinal products, active substances and excipients (EMA/CVMP/VICH/502/1999) - Revision 2

Paediatric investigation plans

23/04/2026

Opinion/decision on a Paediatric investigation plan (PIP): Skyrizi, risankizumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Dermatology, PIP number: P/0497/2022

Orphan designations

24/04/2026

Orphan designation: diazoxide choline Treatment of Prader-Willi syndrome, 12/10/2017 Positive

New medicines and opinions: human

24/04/2026

Human medicines European public assessment report (EPAR): Cenrifki, tolebrutinib, Status: Opinion

MedWatch Safety Alerts RSS Feed

29/04/2026

Insulin Pump Recall: Insulet Removes Certain Omnipod 5 Pods

What's New: Drugs RSS Feed

30/04/2026

April 30, 2026: Meeting of the Oncologic Drugs Advisory Committee Meeting Announcement - 04/30/2026

FDA Drug Safety Podcasts

02/01/2025

Serious liver injury being observed in patients without cirrhosis taking Ocaliva (obeticholic acid) to treat primary biliary cholangitis